Harnessing Technology to Leverage Data and Transform Medicine
Guildford, UK, and Burlington, Mass., April 4, 2011 – IDBS, a global provider of innovative enterprise data management, analytics and modeling solutions, today announced it will present at this year’s Bio-IT World Conference to be held April 12-14 in Boston. The 10th annual Bio-IT World Conference brings together life sciences, pharmaceutical, clinical, healthcare, and IT professionals from around the world and provides a forum for sharing information and discussing the enabling technologies that are driving biomedical research and the drug development process.
Clinical, ‘omic, CRO and validated data are true capital assets of pharmaceuticals R&D. Dr. Paul Denny-Gouldson, VP Translational Medicine and Head of IDBS Global Healthcare Unit, will present a session entitled, ‘Converting Data Overload into Data Assets: The Enabling Role of High Context Data Management for R&D’. He will discuss how the agile progression from target to candidate requires the orchestration of diverse scientific disciplines, each generators and consumers of data, and will highlight how instant access across this entire data landscape is now a must-have capability for speeding innovative products to market.
In addition, IDBS customer, Mick Correll, Associate Director, Center for Cancer Computational Biology, Dana-Farber Cancer Institute, will be speaking on a revolutionary new way to support collaborative research in the genetics of chronic lung disease. His session, ‘Lung Genomics Research Consortium: Building a Translational Research Portal to Improve the Molecular Understanding of Lung Disease’, will discuss how a portal addresses many needs, including supporting uploading of large experimental data sets, assessing available samples and their characteristics, sampling and tracking data across a distributed consortium, and applying sophisticated and automated analytical tools. Attendees will learn about the project requirements, solution design, and commercial and open source tools that were utilized to construct the system.
Bio-IT World will be held April 12-14 at the World Trade Center in Boston. Mr. Correll will speak on Wednesday, April 13, at 11:30 am. Dr. Denny-Gouldson will speak on Wednesday, April 13, at 2:45 pm, and will chair that afternoon’s Translational Informatics and Knowledge Management theme. IDBS will be exhibiting at the show in booth 203 with demonstrations including a preview of IDBS’ innovative new mobile informatics solutions. For more information and to register, visit www.bio-itworldexpo.com.
IDBS is a global provider of innovative enterprise data management, analytics and modeling solutions. The company’s uniquely sophisticated platform technologies are used by more than 200 pharmaceutical companies, major healthcare providers, global leaders in academic study, and high tech companies to increase efficiency, reduce costs and improve the productivity of industrial R&D and clinical research. IDBS is clearly differentiated by its unique combination of award-winning enterprise technologies and domain knowledge in R&D.
IDBS’ solutions help scientists, hospitals and R&D businesses produce the world’s newest therapeutics, diagnostics and personalized treatments, faster, cleaner engines and fuels, breakthroughs in productive agriculture, healthy, safer food products, and high tech materials and consumer products.
Founded in 1989 and privately held, IDBS is headquartered in Guildford, UK with a direct sales and support presence worldwide. IDBS is a Profit Track 100 company and the recipient of multiple awards including the Frost and Sullivan ‘Enabling Technology’ Award in R&D data management for 2010 and Queen’s Award for International Trade 2011. Further information can be found at www.idbs.com, or follow us on Twitter @IDBSsoftware.